Chronic Challenges in Endometrial Cancer: Recurrence and Second-Line Therapy

Experts Ritu Salani, MD, MBA, and Bhavana Pothuri, MD, discuss the prevalence of patients with recurrent endometrial cancer, challenges in responding to chemotherapy, and the potential for improved treatment options in the second-line setting.

Related Keywords

Bhavana Pothuri , ,Optimizing Therapy ,Endometrial Cancer ,Recent Data Highlights ,Second Line Therapy ,Ritu Salani ,Chemotherapy ,Recurrent Cancer ,Partial Disease ,Persistent Disease ,Refractory Patients ,Mismatch Repair Deficient ,Platinum Based Regimen ,Immunotherapy ,Disease Free Interval ,Treatment Challenges ,Pre Treatment ,Endometrial Cancer Recurrence ,